Jin Medical International Ltd. (ZJYL) Market Cap & Valuation Ratios
Jin Medical International Ltd. (ZJYL) has a market cap of $16.0M, a trailing P/E of 205.0 and a price-to-sales ratio of 0.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-03-31 · read by EquiReason
- Market cap
- 16.0M
- P/E TTM
- 205.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ZJYL | 0.0 | 205.0 | 0.3 | 10.3 | — | -14% | 2% | 1% |
| SI | 0.4 | — | 5.4 | — | -11.5% | +61% | -59% | -31% |
| CARL | 0.4 | — | 5.4 | — | -9.0% | +65% | -61% | -72% |
| EMBC | 0.4 | 4.6 | 1.6 | 6.1 | — | -8% | 22% | 26% |
| OBIO | 0.3 | — | 8.2 | — | — | +986% | -181% | -172% |
| SMTI | 0.3 | — | 3.0 | 29.4 | 1.5% | +13% | 8% | 17% |
| OSUR | 0.3 | — | 1.1 | — | — | -19% | -48% | -36% |
| UTMD | 0.2 | 22.6 | 4.1 | 12.6 | 4.8% | -7% | 28% | 24% |
| PMI | 0.0 | — | 2.8 | — | — | +41% | -248% | -531% |
| CTSO | 0.0 | — | 0.8 | — | — | +3% | -35% | -93% |
| GUTS | 0.0 | — | — | — | — | — | — | — |
| Median of these 10 | 13.6 | 3.0 | 12.6 | -3.7% | +13% | -48% | -36% |
P/E 205.0 vs. a peer median of 13.6; EV/Sales 0.3 vs. 3.0. ZJYL's own P/E sits at the 12th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesSI and CARL and OBIO and SMTI and OSUR and PMI and CTSO and GUTS have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Jin Medical International Ltd. — questions
- What is Jin Medical International Ltd.'s market cap?
- $16.0M.
- What is Jin Medical International Ltd.'s P/E ratio?
- 205.0 on trailing twelve-month earnings to 2026-03-31.
- What is Jin Medical International Ltd.'s price-to-sales ratio?
- 0.8.
Every figure on this page comes from Jin Medical International Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.